| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |